Monoclonal antibodies specific for the E2 glycoprotein of hepatitis C virus and their use in the diagnosis, treatment, and prevention of hepatitis C
Details for Australian Patent Application No. 2002243259 (hide)
International Classifications
Event Publications
6 February 2003 Application Open to Public Inspection
Published as AU-B-2002243259
7 February 2008 Application Accepted
Published as AU-B-2002243259
5 June 2008 Standard Patent Sealed
25 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002243260-METHODS FOR AMELIORATING CHILDHOOD INFECTIONS
2002243258-FAST NETWORK SIMULATION USING NETWORK DECOMPOSITION
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser